Evaluation of anti oxidative effect of linagliptin on type 2 diabetic patients.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 15 Feb 2018
At a glance
- Drugs Linagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 30 Mar 2016 Status changed from recruiting to active, no longer recruiting.
- 03 Oct 2014 New trial record